PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1627892
PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1627892
The contraceptive market is expected to grow at a CAGR of 6.48%, reaching a market size of US$47.386 billion in 2030 from US$34.613 billion in 2025.
Contraception is the application that prevents a woman from pregnancy through medications or devices. Other commonly known as fertility control and birth control. The market is expected to continue growing as the incidence of STDs rises. More women are seeking contraceptive medicines and devices, particularly among young women who are beginning to use contraception as they attain higher levels of education.
Furthermore, the health risks posed by teenage pregnancy, increased awareness regarding modern contraceptive methods, and a growing preference for oral contraceptives as the principal method to avoid unintended pregnancy are expected to drive market growth over the next few years.
Contraceptive Market Drivers
Government measures to control population growth in various countries have increased awareness of family planning and contraception among women in both rural and urban areas. Additionally, rising incidences of unintended pregnancies have led to increased utilization of oral contraceptives, especially in developed markets. Particularly in Asian countries, the population is expanding at an incredible rate, impacting the microeconomic balance. The public and private sectors are working together to control this growing population, which should benefit sex education and the use of contraceptives in the years to come. This is expected to drive the market revenue for oral contraceptives during the forecast period.
The market growth in North America includes the inclination of young people toward sexual activities and the high awareness of reproductive health and contraception among them regarding the matters. Teenagers in the regions need contraceptives more due to the introduction and spread of cheap generic products and devices. The expansion of publicly funded family planning services and the rise in social organization efforts in the US to increase access to contraception. Most importantly, the two government-aided initiatives where insurance covers contraceptive methods- the Affordable Care Act and Title X- have made these products accessible and affordable.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence